These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30323586)

  • 1. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
    Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
    Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts barrier breaking via TGF-β blockade paved way for docetaxel micelles delivery to treat pancreatic cancer.
    Pang N; Yang Z; Zhang W; Du Y; Zhang L; Li X; Peng Y; Qi X
    Int J Pharm; 2024 Nov; 665():124706. PubMed ID: 39277152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
    Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
    Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
    Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranilast inhibits the function of cancer-associated fibroblasts responsible for the induction of immune suppressor cell types.
    Ohshio Y; Hanaoka J; Kontani K; Teramoto K
    Scand J Immunol; 2014 Dec; 80(6):408-16. PubMed ID: 25224016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner.
    Papageorgis P; Polydorou C; Mpekris F; Voutouri C; Agathokleous E; Kapnissi-Christodoulou CP; Stylianopoulos T
    Sci Rep; 2017 Apr; 7():46140. PubMed ID: 28393881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
    Wang AT; Liang DS; Liu YJ; Qi XR
    Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast.
    Ochi K; Suzawa K; Thu YM; Takatsu F; Tsudaka S; Zhu Y; Nakata K; Takeda T; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Shien T; Okamoto Y; Tomida S; Toyooka S
    Cancer Sci; 2022 Oct; 113(10):3428-3436. PubMed ID: 35871750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.
    Cao Y; Cao W; Qiu Y; Zhou Y; Guo Q; Gao Y; Lu N
    Pharmacol Res; 2020 Sep; 159():104981. PubMed ID: 32492489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversing activity of cancer associated fibroblast for staged glycolipid micelles against internal breast tumor cells.
    Zhu Y; Yu F; Tan Y; Hong Y; Meng T; Liu Y; Dai S; Qiu G; Yuan H; Hu F
    Theranostics; 2019; 9(23):6764-6779. PubMed ID: 31660067
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links.
    Koo AN; Min KH; Lee HJ; Lee SU; Kim K; Kwon IC; Cho SH; Jeong SY; Lee SC
    Biomaterials; 2012 Feb; 33(5):1489-99. PubMed ID: 22130564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
    Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core-shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts.
    Kovács D; Igaz N; Marton A; Rónavári A; Bélteky P; Bodai L; Spengler G; Tiszlavicz L; Rázga Z; Hegyi P; Vizler C; Boros IM; Kónya Z; Kiricsi M
    J Nanobiotechnology; 2020 Jan; 18(1):18. PubMed ID: 31964403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.
    Cheng WJ; Lin SY; Chen M; Chen LC; Ho HO; Chuang KH; Sheu MT
    Int J Nanomedicine; 2021; 16():4017-4030. PubMed ID: 34140769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.